A Study of PATAS Trifluoroacetate Using Single Ascending Doses in Healthy Volunteers

Summary

The primary objective of this study is to evaluate safety and tolerability of single subcutaneous (SC) doses of PATAS in healthy subjects. The secondary objective of this study is to determine the pharmacokinetics (PK) of single SC doses of PATAS in healthy subjects.

Timeline

Start

2026-01-27

Primary completion

2026-07-30

Completion

2026-09-30

Drugs

Indications